03 July 2024 : Clinical Research
Cystatin SN (CST1) Is a Poor Independent Prognostic Biomarker for Gastrointestinal Diffuse Large B-Cell Lymphoma
Jie Wang1ABCDEFG*, Ming Yang2CD, Sheng Chen2CEF, Hongbo Zhu1AB, Zhirong Zhang1CDDOI: 10.12659/MSM.943551
Med Sci Monit 2024; 30:e943551
Figure 2 The survival curves of different subgroups with CST1 expression and other clinicopathological factorsThe patients were stratified into different subsets according to CST1 expression in GI (A), CST1 expression in stomach (B), CST1 expression in intestine (C), serum LDH (D), PS (E), Lugano stage (F), and PI (G). The survival curves of different subgroups were plotted by the Kaplan-Meier method, and statistical significance was analyzed by the log-rank test. SPSS 22.0 and Adobe Illustrator CS5 were used to generate this figure.